Literature DB >> 7810900

Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization.

H Y Kim1, T C Wang, Y C Ma.   

Abstract

An improved technique for phospholipid molecular species analysis was developed using high-performance liquid chromatography/mass spectrometry with the electrospray interface. Using the 0.5% ammonium hydroxide in a water-methanol-hexane mixture and a C-18 column, complex mixtures of phospholipid molecular species were separated and detected mainly as protonated or natriated molecular species. The response was linear over 2 orders of magnitude, allowing quantification of each molecular species. In comparison to the existing LC/MS techniques, marked improvement in sensitivity was observed. The present quantification limit is approximately 0.5 pmol before split (5 fmol after 1/100 split). The relative responses were more dependent on the head group identity rather than fatty acyl composition within a phospholipid class. In general, phosphatidylcholine (PC) species are most sensitively detected followed by phosphatidylethanolamine (PE) species. The sensitivity of phosphatidylserine (PS) in the positive ion mode is approximately 20 times less in comparison to PC under our condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810900     DOI: 10.1021/ac00094a020

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  54 in total

1.  Structural determination of sphingomyelin by tandem mass spectrometry with electrospray ionization.

Authors:  F F Hsu; J Turk
Journal:  J Am Soc Mass Spectrom       Date:  2000-05       Impact factor: 3.109

Review 2.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

Review 3.  Electrospray ionization with low-energy collisionally activated dissociation tandem mass spectrometry of glycerophospholipids: mechanisms of fragmentation and structural characterization.

Authors:  Fong-Fu Hsu; J Turk
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-02-21       Impact factor: 3.205

4.  The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery.

Authors:  Thomas O Metz; Qibin Zhang; Jason S Page; Yufeng Shen; Stephen J Callister; Jon M Jacobs; Richard D Smith
Journal:  Biomark Med       Date:  2007-06       Impact factor: 2.851

5.  Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids.

Authors:  Xianlin Han; Kui Yang; Jingyue Yang; Kora N Fikes; Hua Cheng; Richard W Gross
Journal:  J Am Soc Mass Spectrom       Date:  2006-01-18       Impact factor: 3.109

6.  Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry.

Authors:  X Han; R W Gross
Journal:  J Am Soc Mass Spectrom       Date:  1995-12       Impact factor: 3.109

7.  Revealing the role of phosphatidylserine in shear stress-mediated protection in endothelial cells.

Authors:  Julie K Freed; Michael R Shortreed; Christopher J Kleefisch; Lloyd M Smith; Andrew S Greene
Journal:  Endothelium       Date:  2008 Jul-Aug

8.  The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

Authors:  A Puri; P Hug; K Jernigan; J Barchi; H Y Kim; J Hamilton; J Wiels; G J Murray; R O Brady; R Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Effects of docosapentaenoic acid on neuronal apoptosis.

Authors:  Hee-Yong Kim; Mohammed Akbar; Audrey Lau
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

10.  Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Authors:  Kei Hamazaki; Kwang H Choi; Hee-Yong Kim
Journal:  J Psychiatr Res       Date:  2010-01-06       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.